ID   PPIG_HUMAN              Reviewed;         754 AA.
AC   Q13427; D3DPC5; D3DPC6; O00706; Q53R40; Q53SN4; Q96DG9;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   07-APR-2021, entry version 186.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase G;
DE            Short=PPIase G;
DE            Short=Peptidyl-prolyl isomerase G;
DE            EC=5.2.1.8 {ECO:0000269|PubMed:20676357};
DE   AltName: Full=CASP10;
DE   AltName: Full=Clk-associating RS-cyclophilin;
DE            Short=CARS-Cyp;
DE            Short=CARS-cyclophilin;
DE            Short=SR-cyclophilin;
DE            Short=SR-cyp;
DE            Short=SRcyp;
DE   AltName: Full=Cyclophilin G;
DE   AltName: Full=Rotamase G;
GN   Name=PPIG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANT
RP   ASP-699.
RC   TISSUE=T-cell;
RX   PubMed=8973360; DOI=10.1016/s0378-1119(96)00436-2;
RA   Nestel F.P., Colwill K., Harper S., Pawson T., Anderson S.K.;
RT   "RS cyclophilins: identification of an NK-TR1-related cyclophilin.";
RL   Gene 180:151-155(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH CLK1 AND RNA
RP   POLYMERASE II, DOMAIN, AND VARIANT ASP-699.
RC   TISSUE=B-cell;
RX   PubMed=9153302; DOI=10.1093/nar/25.11.2055;
RA   Bourquin J.-P., Stagljar I., Meier P., Moosmann P., Silke J., Baechi T.,
RA   Georgiev O., Schaffner W.;
RT   "A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-
RT   terminal domain of RNA polymerase II.";
RL   Nucleic Acids Res. 25:2055-2061(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH PNN, AND SUBCELLULAR LOCATION.
RX   PubMed=15358154; DOI=10.1016/j.bbrc.2004.07.013;
RA   Lin C.L., Leu S., Lu M.C., Ouyang P.;
RT   "Over-expression of SR-cyclophilin, an interaction partner of nuclear
RT   pinin, releases SR family splicing factors from nuclear speckles.";
RL   Biochem. Biophys. Res. Commun. 321:638-647(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-358 AND SER-687, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315 AND SER-696, VARIANT
RP   [LARGE SCALE ANALYSIS] ASP-699, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254; SER-256; SER-257;
RP   SER-259; SER-397 AND SER-687, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413; SER-415; SER-687;
RP   SER-690; SER-696; THR-748 AND SER-753, VARIANT [LARGE SCALE ANALYSIS]
RP   ASP-699, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-358; SER-687;
RP   SER-690 AND THR-748, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-358; SER-386;
RP   SER-397; SER-687; SER-745 AND THR-748, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-290; SER-744; SER-745 AND
RP   THR-748, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-392 AND LYS-693, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [16] {ECO:0007744|PDB:2GW2}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1-179, FUNCTION, CATALYTIC
RP   ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=20676357; DOI=10.1371/journal.pbio.1000439;
RA   Davis T.L., Walker J.R., Campagna-Slater V., Finerty P.J., Paramanathan R.,
RA   Bernstein G., MacKenzie F., Tempel W., Ouyang H., Lee W.H.,
RA   Eisenmesser E.Z., Dhe-Paganon S.;
RT   "Structural and biochemical characterization of the human cyclophilin
RT   family of peptidyl-prolyl isomerases.";
RL   PLoS Biol. 8:E1000439-E1000439(2010).
CC   -!- FUNCTION: PPIase that catalyzes the cis-trans isomerization of proline
CC       imidic peptide bonds in oligopeptides and may therefore assist protein
CC       folding (PubMed:20676357). May be implicated in the folding, transport,
CC       and assembly of proteins. May play an important role in the regulation
CC       of pre-mRNA splicing. {ECO:0000269|PubMed:20676357}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-peptidylproline (omega=180) = [protein]-
CC         peptidylproline (omega=0); Xref=Rhea:RHEA:16237, Rhea:RHEA-
CC         COMP:10747, Rhea:RHEA-COMP:10748, ChEBI:CHEBI:83833,
CC         ChEBI:CHEBI:83834; EC=5.2.1.8;
CC         Evidence={ECO:0000269|PubMed:20676357};
CC   -!- ACTIVITY REGULATION: Inhibited by cyclosporin A (CsA).
CC       {ECO:0000305|PubMed:20676357}.
CC   -!- SUBUNIT: Interacts with CLK1, PNN and with the phosphorylated C-
CC       terminal domain of RNA polymerase II. {ECO:0000269|PubMed:15358154,
CC       ECO:0000269|PubMed:9153302}.
CC   -!- INTERACTION:
CC       Q13427; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-396072, EBI-10181188;
CC       Q13427; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-396072, EBI-739624;
CC       Q13427; O75553: DAB1; NbExp=3; IntAct=EBI-396072, EBI-7875264;
CC       Q13427; Q9UI36-2: DACH1; NbExp=3; IntAct=EBI-396072, EBI-10186082;
CC       Q13427; Q96C98: FHL3; NbExp=3; IntAct=EBI-396072, EBI-10229248;
CC       Q13427; Q8NC69: KCTD6; NbExp=3; IntAct=EBI-396072, EBI-2511344;
CC       Q13427; P17931: LGALS3; NbExp=3; IntAct=EBI-396072, EBI-1170392;
CC       Q13427; Q6NVH9: LGALS3; NbExp=3; IntAct=EBI-396072, EBI-10187804;
CC       Q13427; Q15365: PCBP1; NbExp=2; IntAct=EBI-396072, EBI-946095;
CC       Q13427; Q9UL42: PNMA2; NbExp=3; IntAct=EBI-396072, EBI-302355;
CC       Q13427; Q96CD2: PPCDC; NbExp=3; IntAct=EBI-396072, EBI-724333;
CC       Q13427; Q14498: RBM39; NbExp=3; IntAct=EBI-396072, EBI-395290;
CC       Q13427; Q16637: SMN2; NbExp=4; IntAct=EBI-396072, EBI-395421;
CC       Q13427; Q12800: TFCP2; NbExp=3; IntAct=EBI-396072, EBI-717422;
CC       Q13427; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-396072, EBI-741515;
CC       Q13427; PRO_0000037309 [P0C6X7]: rep; Xeno; NbExp=4; IntAct=EBI-396072, EBI-25475797;
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:15358154}.
CC       Nucleus speckle {ECO:0000269|PubMed:15358154}. Note=Colocalizes with
CC       RNA splicing factors at nuclear speckles.
CC       {ECO:0000269|PubMed:15358154}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13427-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13427-2; Sequence=VSP_009662, VSP_009663;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:8973360}.
CC   -!- DOMAIN: The RS domain is required for the interaction with the
CC       phosphorylated C-terminal domain of RNA polymerase II.
CC       {ECO:0000269|PubMed:9153302}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U40763; AAB40347.1; -; mRNA.
DR   EMBL; X99717; CAA68053.1; -; mRNA.
DR   EMBL; AC093899; AAY24119.1; -; Genomic_DNA.
DR   EMBL; AC016772; AAY24233.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11267.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11268.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11269.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11270.1; -; Genomic_DNA.
DR   EMBL; BC001555; AAH01555.1; -; mRNA.
DR   CCDS; CCDS2235.1; -. [Q13427-1]
DR   PIR; JC5314; JC5314.
DR   RefSeq; NP_004783.2; NM_004792.2. [Q13427-1]
DR   RefSeq; XP_005247023.1; XM_005246966.1. [Q13427-1]
DR   RefSeq; XP_005247024.1; XM_005246967.1. [Q13427-1]
DR   PDB; 2GW2; X-ray; 1.80 A; A=1-179.
DR   PDB; 2WFI; X-ray; 0.75 A; A=1-177.
DR   PDB; 2WFJ; X-ray; 0.75 A; A=1-177.
DR   PDB; 5YZG; EM; 4.10 A; 3=1-754.
DR   PDBsum; 2GW2; -.
DR   PDBsum; 2WFI; -.
DR   PDBsum; 2WFJ; -.
DR   PDBsum; 5YZG; -.
DR   SMR; Q13427; -.
DR   BioGRID; 114761; 69.
DR   IntAct; Q13427; 51.
DR   MINT; Q13427; -.
DR   STRING; 9606.ENSP00000260970; -.
DR   BindingDB; Q13427; -.
DR   ChEMBL; CHEMBL3707467; -.
DR   DrugBank; DB00172; Proline.
DR   iPTMnet; Q13427; -.
DR   PhosphoSitePlus; Q13427; -.
DR   BioMuta; PPIG; -.
DR   DMDM; 229462749; -.
DR   EPD; Q13427; -.
DR   jPOST; Q13427; -.
DR   MassIVE; Q13427; -.
DR   MaxQB; Q13427; -.
DR   PaxDb; Q13427; -.
DR   PeptideAtlas; Q13427; -.
DR   PRIDE; Q13427; -.
DR   ProteomicsDB; 59415; -. [Q13427-1]
DR   ProteomicsDB; 59416; -. [Q13427-2]
DR   Antibodypedia; 19292; 273 antibodies.
DR   Ensembl; ENST00000260970; ENSP00000260970; ENSG00000138398. [Q13427-1]
DR   Ensembl; ENST00000414307; ENSP00000402222; ENSG00000138398. [Q13427-2]
DR   Ensembl; ENST00000433207; ENSP00000408683; ENSG00000138398. [Q13427-1]
DR   Ensembl; ENST00000448752; ENSP00000407083; ENSG00000138398. [Q13427-1]
DR   Ensembl; ENST00000462903; ENSP00000435987; ENSG00000138398. [Q13427-2]
DR   Ensembl; ENST00000676756; ENSP00000503525; ENSG00000138398. [Q13427-1]
DR   Ensembl; ENST00000678499; ENSP00000503136; ENSG00000138398. [Q13427-1]
DR   Ensembl; ENST00000679107; ENSP00000502997; ENSG00000138398. [Q13427-1]
DR   GeneID; 9360; -.
DR   KEGG; hsa:9360; -.
DR   UCSC; uc002uez.4; human. [Q13427-1]
DR   CTD; 9360; -.
DR   DisGeNET; 9360; -.
DR   GeneCards; PPIG; -.
DR   HGNC; HGNC:14650; PPIG.
DR   HPA; ENSG00000138398; Low tissue specificity.
DR   MIM; 606093; gene.
DR   neXtProt; NX_Q13427; -.
DR   OpenTargets; ENSG00000138398; -.
DR   PharmGKB; PA33585; -.
DR   VEuPathDB; HostDB:ENSG00000138398.15; -.
DR   eggNOG; KOG0546; Eukaryota.
DR   GeneTree; ENSGT00940000157954; -.
DR   HOGENOM; CLU_012062_33_6_1; -.
DR   InParanoid; Q13427; -.
DR   OMA; VVQTMEN; -.
DR   OrthoDB; 1403619at2759; -.
DR   PhylomeDB; Q13427; -.
DR   TreeFam; TF318563; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   PathwayCommons; Q13427; -.
DR   BioGRID-ORCS; 9360; 10 hits in 998 CRISPR screens.
DR   ChiTaRS; PPIG; human.
DR   EvolutionaryTrace; Q13427; -.
DR   GeneWiki; PPIG_(gene); -.
DR   GenomeRNAi; 9360; -.
DR   Pharos; Q13427; Tchem.
DR   PRO; PR:Q13427; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q13427; protein.
DR   Bgee; ENSG00000138398; Expressed in sural nerve and 256 other tissues.
DR   ExpressionAtlas; Q13427; baseline and differential.
DR   Genevisible; Q13427; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016018; F:cyclosporin A binding; IDA:UniProtKB.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Isomerase; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Rotamase; Ubl conjugation.
FT   CHAIN           1..754
FT                   /note="Peptidyl-prolyl cis-trans isomerase G"
FT                   /id="PRO_0000064150"
FT   DOMAIN          11..176
FT                   /note="PPIase cyclophilin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00156"
FT   COMPBIAS        180..192
FT                   /note="Arg/Lys-rich (basic)"
FT   COMPBIAS        193..225
FT                   /note="Asp/Glu/Ser-rich"
FT   COMPBIAS        193..208
FT                   /note="Poly-Ser"
FT   COMPBIAS        226..253
FT                   /note="Arg/Lys-rich (basic)"
FT   COMPBIAS        540..639
FT                   /note="Arg/Ser-rich (RS domain)"
FT   COMPBIAS        621..626
FT                   /note="Poly-Arg"
FT   MOD_RES         254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         256
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         356
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         358
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         386
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         690
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         696
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         744
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         745
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         748
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         753
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CROSSLNK        392
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        693
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         340..357
FT                   /note="RYRTPSRSRSRDRFRRSE -> VGDSFPRDLHNIAFVFLK (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009662"
FT   VAR_SEQ         358..754
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009663"
FT   VARIANT         445
FT                   /note="D -> E (in dbSNP:rs1050354)"
FT                   /id="VAR_055084"
FT   VARIANT         699
FT                   /note="N -> D (in dbSNP:rs8207)"
FT                   /evidence="ECO:0000269|PubMed:8973360,
FT                   ECO:0000269|PubMed:9153302, ECO:0007744|PubMed:17525332,
FT                   ECO:0007744|PubMed:20068231"
FT                   /id="VAR_055085"
FT   STRAND          9..16
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          19..28
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   TURN            30..32
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   HELIX           34..45
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   TURN            46..48
FT                   /evidence="ECO:0007744|PDB:2WFJ"
FT   TURN            52..54
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          56..58
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          64..69
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   TURN            70..72
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          73..76
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   TURN            79..81
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          82..85
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          109..112
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          114..116
FT                   /evidence="ECO:0007744|PDB:2WFJ"
FT   STRAND          124..129
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   HELIX           132..134
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   TURN            135..137
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          140..146
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   HELIX           148..155
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          165..167
FT                   /evidence="ECO:0007744|PDB:2WFI"
FT   STRAND          169..176
FT                   /evidence="ECO:0007744|PDB:2WFI"
SQ   SEQUENCE   754 AA;  88617 MW;  D4884808D8060CD6 CRC64;
     MGIKVQRPRC FFDIAINNQP AGRVVFELFS DVCPKTCENF RCLCTGEKGT GKSTQKPLHY
     KSCLFHRVVK DFMVQGGDFS EGNGRGGESI YGGFFEDESF AVKHNKEFLL SMANRGKDTN
     GSQFFITTKP TPHLDGHHVV FGQVISGQEV VREIENQKTD AASKPFAEVR ILSCGELIPK
     SKVKKEEKKR HKSSSSSSSS SSDSDSSSDS QSSSDSSDSE SATEEKSKKR KKKHRKNSRK
     HKKEKKKRKK SKKSASSESE AENLEAQPQS TVRPEEIPPI PENRFLMRKS PPKADEKERK
     NREREREREC NPPNSQPASY QRRLLVTRSG RKIKGRGPRR YRTPSRSRSR DRFRRSETPP
     HWRQEMQRAQ RMRVSSGERW IKGDKSELNE IKENQRSPVR VKERKITDHR NVSESPNRKN
     EKEKKVKDHK SNSKERDIRR NSEKDDKYKN KVKKRAKSKS RSKSKEKSKS KERDSKHNRN
     EEKRMRSRSK GRDHENVKEK EKQSDSKGKD QERSRSKEKS KQLESKSNEH DHSKSKEKDR
     RAQSRSRECD ITKGKHSYNS RTRERSRSRD RSRRVRSRTH DRDRSRSKEY HRYREQEYRR
     RGRSRSRERR TPPGRSRSKD RRRRRRDSRS SEREESQSRN KDKYRNQESK SSHRKENSES
     EKRMYSKSRD HNSSNNSREK KADRDQSPFS KIKQSSQDNE LKSSMLKNKE DEKIRSSVEK
     ENQKSKGQEN DHVHEKNKKF DHESSPGTDE DKSG
//
